Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0036341 (schizophrenia)
 60,220 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Fifty-eight patients with slow progressive schizophrenia combined with alcoholism have been examined. Different variants of affective pathology described determined an alcohol addiction in patients with slow progressive schizophrenia. According to the structure of affective disorders and related types of excessive drinking, 3 groups of patients were identified. Group 1 was characterized by negative affection with detachment, continuous (progressive) type of alcoholism course and constant type of alcohol use; group 2 was characterized by positive affection with undulatory course of alcoholism and alcohol use, pseudo-drinking-bout type. Group 3 was distinguished by positive affection with distinct timing of disorder appearance, periodic course of alcoholism and spontaneous form of alcohol drinking. The most unfavorable prognosis was for group 1 and favorable one--for group 3.
 ...
PMID:[Clinical characteristics of patients with slow progressive schizophrenia combined with alcoholism]. 1462 83

Polydipsia and water intoxication have been found to be care problems in people with schizophrenia in many countries. This Japanese study measured the body fluid distribution and body fat of 80 males with long standing schizophrenia and compared this to that of 64 healthy males, using bioelectrical impedance spectrum analysis (BIS). Participants with schizophrenia exhibited significantly lower percentages of intracellular fluid and total body fluid, and significantly higher percentages of fat. Moreover, the percentage of extracellular fluid was distributed over a wider range. When the percentage body fluid was compared between the two groups by matching body mass index and body fat, intracellular fluid was significantly lower for those participants with schizophrenia. There findings suggest that nurses and other health professionals need to be very cautious when attempting to modify the excessive drinking of fluids by patients with schizophrenia. In mistakenly trying to prevent water intoxication, they may in fact be contributing to dehydration.
 ...
PMID:Comparison of the body fluid levels in healthy individuals and those with schizophrenia in Japan: using the bioelectrical impedance method. 1768 75

Primary polydipsia, excessive drinking without known medical cause, is especially associated with a diagnosis of schizophrenia. We used animal models of schizophrenia-like symptoms to examine the effects on schedule-induced polydipsia: post-weaning social isolation rearing, subchronic MK-801 treatment (an NMDA-receptor antagonist) or the two combined. Male, Sprague-Dawley rats reared in groups or in isolation beginning at postnatal day 21 were further divided to receive subchronic MK-801 (0.5 mg/kg twice daily) or saline for 7 days beginning on postnatal day 62. Following a 4-day withdrawal period, all groups were trained on a schedule-induced polydipsia paradigm. Under food-restriction, animals reared in isolation and receiving food pellets at 1-min intervals developed significantly more drinking behavior than those reared with others. The addition of subchronic MK-801 treatment did not significantly augment the amount of water consumed. These findings suggest a predisposition to polydipsia is a schizophrenia-like behavioral effect of post-weaning social isolation.
 ...
PMID:Increased drinking following social isolation rearing: implications for polydipsia associated with schizophrenia. 2344 Nov 61

A man in his twenties was diagnosed with schizophrenia in his late teens. The night before his death, his family reported he drank a large amount of water, vomited, collapsed, and snored loudly while sleeping, but they did not view the event seriously as he did it routinely. The following morning, he was found dead. Autopsy revealed hyponatremia by water intoxication as the cause of death. Water intoxication has various causes. In this case, 610 ng/mL olanzapine was detected in serum samples. Although this concentration is not as high as the fatal concentrations reported in past studies, it might have caused some adverse effects. Furthermore, the observation that excessive drinking behavior started after the dose of olanzapine was increased suggests a possibility that olanzapine aggravated water intoxication.
 ...
PMID:Fatal water intoxication during olanzapine treatment: a case report. 2438 43

Primary polydipsia (PP) has been defined as excessive intake of fluids. However, the pathogenesis of PP remains unexplored. Different theories include a dysfunction in the thirst mechanism, involvement of the hippocampus, stress-reducing behaviour and lesion occurrences in specific areas of the brain. Most studies have been performed in the psychiatric setting, indicating that PP coincides with schizophrenia, anxiety disorder and depression. However, an increasing number of case reports emphasise the incidence of PP in non-psychiatric patients. As often recommended by healthcare professions and in life-style programmes, the phenomenon of excessive fluid intake appears to be growing, especially in health-conscious and active people. PP is part of the polyuria-polydipsia syndrome, so the differential diagnosis diabetes insipidus (central or nephrogenic) must be excluded. The gold standard when differentiating between these disorders has been the water deprivation test. However, new options for distinguishing between these entities have been proposed e.g., measurement of copeptin, a reliable surrogate marker of the hormone arginine vasopressin (AVP). The major risk of excessive drinking is the development of hyponatraemia and the ensuing complications. In patients with PP, factors reducing the renal excretory capacity of the kidney such as acute illness, medications or low solute intake may accumulate in hyponatraemia. Treatment options for PP remain scarce. Different medication and behavioural therapy have been investigated, but never on a large scale and rarely in non-psychiatric patients. This review provides an overview of the pathophysiology, characteristics, complications, and outcomes of patients with PP in the medical and psychiatric patient.
 ...
PMID:Primary polydipsia in the medical and psychiatric patient: characteristics, complications and therapy. 2961 1